| Lymph node stromal cells acquire peptide–MHCII complexes from dendritic cells and induce antigen-specific CD4+ T cell tolerance J Dubrot, FV Duraes, L Potin, F Capotosti, D Brighouse, T Suter, ... Journal of Experimental Medicine 211 (6), 1153-1166, 2014 | 250 | 2014 |
| Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma M Fankhauser, MAS Broggi, L Potin, N Bordry, L Jeanbart, AW Lund, ... Science Translational Medicine 9 (407), eaal4712, 2017 | 214 | 2017 |
| Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours A Mansurov, J Ishihara, P Hosseinchi, L Potin, TM Marchell, A Ishihara, ... Nature biomedical engineering 4 (5), 531-543, 2020 | 157 | 2020 |
| Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events J Ishihara, K Fukunaga, A Ishihara, HM Larsson, L Potin, P Hosseinchi, ... Science Translational Medicine 9 (415), eaan0401, 2017 | 156 | 2017 |
| Targeted antibody and cytokine cancer immunotherapies through collagen affinity J Ishihara, A Ishihara, K Sasaki, SSY Lee, JM Williford, M Yasui, H Abe, ... Science Translational Medicine 11 (487), eaau3259, 2019 | 154 | 2019 |
| Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients MAS Broggi, L Maillat, CC Clement, N Bordry, P Corthésy, A Auger, ... Journal of Experimental Medicine 216 (5), 1091-1107, 2019 | 109 | 2019 |
| Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy JM Williford, J Ishihara, A Ishihara, A Mansurov, P Hosseinchi, ... Science Advances 5 (12), eaay1357, 2019 | 106 | 2019 |
| Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges K Maisel, MS Sasso, L Potin, MA Swartz Advanced Drug Delivery Reviews 114, 43-59, 2017 | 103 | 2017 |
| Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity J Ishihara, A Ishihara, L Potin, P Hosseinchi, K Fukunaga, M Damo, ... Molecular cancer therapeutics 17 (11), 2399-2411, 2018 | 40 | 2018 |
| The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes M Perreau, HC Welles, C Pellaton, B Gjoksi, L Potin, R Martin, A Harari, ... Journal of virology 86 (11), 6279-6285, 2012 | 28 | 2012 |
| Pro-lymphangiogenic VEGFR-3 signaling modulates memory T cell responses in allergic airway inflammation K Maisel, CL Hrusch, JEG Medellin, L Potin, DB Chapel, H Nurmi, ... Mucosal immunology 14 (1), 144-151, 2021 | 13 | 2021 |
| Antigen presentation via MHC class II by lymphatic endothelial cells dampens CD4+ T cell response (IRC7P. 436) L Potin, L Maillat, J Dubrot, F Duraes, S Hugues, M Swartz The Journal of Immunology 194 (1_Supplement), 128.17-128.17, 2015 | 2 | 2015 |
| Lymphatic vessels regulate exosome trafficking from tumors L Maillat, L Potin, WW Kilarski, MA Swartz Cancer Research 79 (13_Supplement), 4520-4520, 2019 | 1 | 2019 |
| TGF-β Signaling Prevents MHC Class II–Expressing Lymphatic Endothelial Cells from Reactivating Human Allogenic Memory CD4+ T Cells R Mezyk-Kopec, L Potin, JE Gomez Medellin, CM Salles, MA Swartz The Journal of Immunology, 2023 | | 2023 |
| Method for treating melanoma using lymphangiogenesis inducers and a melanoma-specific antigen MA Swartz, JA Hubbell, S Yu, E Vokali, M Fankhauser, S Hirosue, ... US Patent 10,980,877, 2021 | | 2021 |
| Abstract B97: The immunomodulatory roles of tumor-associated lymphatics in triple-negative breast cancer P Hosseinchi, L Potin, A Mansurov, L Maillat, JA Hubbell, MA Swartz Cancer Immunology Research 8 (3_Supplement), B97-B97, 2020 | | 2020 |
| Collagen affinity improves safety and efficacy of antibody and cytokine cancer immunotherapies J Ishihara, A Ishihara, A Mansurov, K Sasaki, SS Lee, JM Williford, L Potin, ... Cancer Research 79 (13_Supplement), 1553-1553, 2019 | | 2019 |
| Abstract IA07: Using matrix protein affinity to modulate the tumor microenvironment J Ishihara, A Ishihara, K Saskai, SSY Lee, M Yasui, H Abe, L Potin, ... Cancer Immunology Research 7 (2_Supplement), IA07-IA07, 2019 | | 2019 |
| Inducing therapeutic lymphangiogenesis for potentiating cancer immunotherapy in melanoma L Potin, L Maillat, PS Briquez, JA Hubbell, MA Swartz Cancer Research 78 (13_Supplement), 1750-1750, 2018 | | 2018 |
| 13 Exploring mechanisms of tumour lymphangiogenesis to potentiate immunotherapies in melanoma L Potin, L Maillat, PS Briquez, M Fankhauser, JA Hubbell, MA Swartz ESMO Open 3, A6, 2018 | | 2018 |
Melody SwartzProfessor of Molecular Engineering, University of ChicagoVerified email at uchicago.edu
